PDF herunterladen
CC BY-NC-ND 4.0 · J Lab Physicians 2018; 10(02): 130-134
DOI: 10.4103/JLP.JLP_172_16
Original Article

Asymptomatic thyroid dysfunction in human immunodeficiency virus-1-infected subjects

Mathias Abiodun Emokpae
Department of Medical Laboratory Science, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, Nigeria
,
Imwonghomwen Mercy Akinnuoye
Department of Medical Laboratory Science, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, Nigeria
Department of Federal Medical Center, Owo, Ondo State, Nigeria
› Institutsangaben Financial support and sponsorship Nil.
› Weitere Informationen
Auch verfügbar auf
  als PDF herunterladen Lizenzen und Reprints

ABSTRACT

BACKGROUND: Thyroid hormone abnormalities have been reported elsewhere in human immunodeficiency virus-1 (HIV-1)-infected individuals, but such studies in Nigerians are scarce in literature.

OBJECTIVE: To evaluate thyroid function in HIV-1-infected individuals and to correlate thyroid function parameters with cluster of differentiation (CD4+) cell count.

MATERIALS AND METHODS: Total thyroxine (T4), total triiodothyronine (T3), thyroid-stimulating hormone (TSH), and CD4+ were estimated in 100 HIV-1-positive individuals on highly active antiretroviral therapy (HAART), 100 HIV-1-positive HAART naïve, and 100 HIV-1-negative controls. The mean values were compared between the groups, and CD4+ cell count was correlated with measured thyroid hormones.

RESULTS: Thyroid function abnormalities were seen in 52 HIV-1-positive individuals on HAART and 56 individuals without HAART treatment. The pattern of thyroid hormone abnormalities is similar in both groups. Among the individuals on HAART, 10 had subclinical hypothyroid, 42 sick euthyroid, and 48 had normal thyroid hormones levels. Similarly, among those without HAART therapy, seven had subclinical hypothyroid, 49 sick euthyroid, and 44 had normal thyroid hormones levels. The HIV-1-positive individuals had significantly lower (P < 0.001) CD4+ cell count, TSH (P < 0.05), T3 (P < 0.01), and T4 (P < 0.001) when compared with controls. On the other hand, HIV-1-positive individuals on HAART had significantly higher (P < 0.01) CD4+ cell count and lower (P< 0.05) T4 levels than the HAART naïve group. CD4+ correlated positively with T4 in HIV-1-positive individuals on HAART (r = 0.26; P = 0.016) and HAART naïve (r = 0.218; P = 0.038). There was no significant correlation between CD4+ and measured thyroid hormones in the control individuals.

CONCLUSION: Asymptomatic thyroid hormone abnormalities are common in HIV-infected individuals, and these abnormalities are independent of whether the individuals were on HAART or without HAART treatment.

Key words

Cluster of differentiation - human immunodeficiency virus-1 - thyroid-stimulating hormone - total thyroxine - triiodothyronine


Publikationsverlauf

Eingereicht: 29. Dezember 2016

Angenommen: 04. Juli 2017

Artikel online veröffentlicht:
19. Februar 2020

© 2018.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Wang JJ, Zhou JJ, Yuan XL, Li CY, Sheng H, Su B, et al. Hyperthyroidism caused by acquired immune deficiency syndrome. Eur Rev Med Pharmacol Sci 2014;18:875-9.
  • 2 National Agency for the Control of AIDS (NACA). Women, Girls and HIV in Nigeria. Available from: http://naca.gov.ng/index2.php.com. [Last assessed on 2015 Jun 12].
  • 3 Ji S, Jin C, Höxtermann S, Fuchs W, Xie T, Lu X, et al. Prevalence and influencing factors of thyroid dysfunction in HIV-infected patients. Biomed Res Int 2016;2016:3874257.
  • 4 Bongiovanni M, Adorni F, Casana M, Tordato F, Tincati C, Cicconi P, et al. Subclinical hypothyroidism in HIV-infected subjects. J Antimicrob Chemother 2006;58:1086-9.
  • 5 Madeddu G, Spanu A, Chessa F, Calia GM, Lovigu C, Solinas P, et al. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): A longitudinal study. Clin Endocrinol (Oxf) 2006;64:375-83.
  • 6 Hoffmann CJ, Brown TT. Thyroid function abnormalities in HIV-infected patients. Clin Infect Dis 2007;45:488-94.
  • 7 Mylonakis E, Koutkia P, Grinspoon S. Diagnosis and treatment of androgen deficiency in human immunodeficiency virus-infected men and women. Clin Infect Dis 2001;33:857-64.
  • 8 Tang WW, Kaptein EM. Thyroid hormone levels in the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. West J Med 1989;151:627-31.
  • 9 Silva GA, Andrade MC, Sugui Dde A, Nunes RF, Pinto JF, Eyer Silva WA, et al. Association between antiretrovirals and thyroid diseases: A cross-sectional study. Arch Endocrinol Metab 2015;59:116-22.
  • 10 Noureldeen AF, Qusti SY, Khoja GM. Thyroid function in newly diagnosed HIV-infected patients. Toxicol Ind Health 2014;30:919-25.
  • 11 Dobs AS, Dempsey MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988;84:611-6.
  • 12 Sellmeyer DE, Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev 1996;17:518-32.
  • 13 Olivieri A, Sorcini M, Battisti P, Fazzini C, Gilardi E, Sun Y, et al. Thyroid hypofunction related with the progression of human immunodeficiency virus infection. J Endocrinol Invest 1993;16:407-13.
  • 14 Grappin M, Piroth L, Verges B, Sgro C, Mack G, Buisson M, et al. Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS 2000;14:1070-2.
  • 15 Calza L, Manfredi R, Chiodo F. Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002;31:361-3.
  • 16 Beltran S, Lescure FX, El Esper I, Schmit JL, Desailloud R. Subclinical hypothyroidism in HIV-infected patients is not an autoimmune disease. Horm Res 2006;66:21-6.
  • 17 Collazos J, Ibarra S, Mayo J. Thyroid hormones in HIV-infected patients in the highly active antiretroviral therapy era: Evidence of an interrelation between the thyroid axis and the immune system. AIDS 2003;17:763-5.
  • 18 Saravanan P, Dayan CM. Assessment of thyroid function disease: Thyroid autoantibodies. Endocrinol Metab Clin 2001;30:315-37.
  • 19 Chen F, Day SL, Metcalfe RA, Sethi G, Kapembwa MS, Brook MG, et al. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore) 2005;84:98-106.
  • 20 Parsa AA, Bhangoo A. HIV and thyroid dysfunction. Rev Endocr Metab Disord 2013;14:127-31.
  • 21 Madge S, Smith CJ, Lampe FC, Thomas M, Johnson MA, Youle M, et al. No association between HIV disease and its treatment and thyroid function. HIV Med 2007;8:22-7.
  • 22 Lwange S, Lemeshow S. Sample Size Determination in Health Studies. A Practical Manual. Geneva: World Health Organization; 1991. p. 23-41.
  • 23 Thongam S, Keithelakpam S, Singh TY, Singh RL, Singh AM, Ranabir S, et al. Thyroid dysfunction in human immunodeficiency virus-infected children and its correlation with CD4(+) T lymphocyte count. Indian J Endocrinol Metab 2015;19:272-6.
  • 24 Savès M, Raffi F, Capeau J, Rozenbaum W, Ragnaud JM, Perronne C, et al. Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis 2002;34:1396-405.
  • 25 Beltran S, Lescure FX, Desailloud R, Douadi Y, Smail A, El Esper I, et al. Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: A need for screening. Clin Infect Dis 2003;37:579-83.
  • 26 Chiarelli F, Galli L, Verrotti A, di Ricco L, Vierucci A, de Martino M, et al. Thyroid function in children with perinatal human immunodeficiency virus type 1 infection. Thyroid 2000;10:499-505.
  • 27 Nelson M, Powles T, Zeitlin A, Sen P, Scourfield A, Bower M, et al. Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART era. J Acquir Immune Defic Syndr 2009;50:113-4.
  • 28 Sharma N, Sharma LK, Dutta D, Gadpayle AK, Anand A, Gaurav K, et al. Prevalence and predictors of thyroid dysfunction in patients with HIV infection and acquired immunodeficiency syndrome: An Indian perspective. J Thyroid Res 2015;2015:517173.
  • 29 Carvalho LG, Teixeira Pde F, Panico AL, Cohen MV, Pinheiro MF, Barroso PF, et al. Evaluation of thyroid function and autoimmunity in HIV-infected women. Arq Bras Endocrinol Metabol 2014;58:86.
  • 30 Dobs AS, Dempsey MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988;84(3 Pt 2):611-6.
  • 31 Bonfanti P, Valsecchi L, Parazzini F, Carradori S, Pusterla L, Fortuna P, et al. Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study. Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group. J Acquir Immune Defic Syndr 2000;23:236-45.
  • 32 Sokalski KM, Chu J, Mai AY, Qiu AQ, Albert AY, Zanet DL, et al. Endocrine abnormalities in HIV - infected women are associated with peak viral load-the children and women: Antiretrovirals and markers of aging (CARMA) cohort. Clin Endocrinol (Oxf) 2016;84:452-62.
  • 33 Hirschfeld S, Laue L, Cutler GB Jr, Pizzo PA. Thyroid abnormalities in children infected with human immunodeficiency virus. J Pediatr 1996;128:70-4.